Humoral immunity to diphtheria, tetanus, measles, and hemophilus influenzae type b in children with acute lymphoblastic leukemia and response to re-vaccination

Pediatric Blood and Cancer

Volumn 53, Issue 6, 2009, Pages 967-972

  Zengin, Emine ^a   Sarper, Nazan ^a,b  

^a KOCAELI UNIVERSITY   (Turkey)

^b Department of Pediatrics ^*  (Turkey)

Author keywords

Acute lymphoblastic leukemia; Diphtheria; Hib; Measles; Re vaccination; Tetanus

Indexed keywords

DIPHTHERIA VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MEASLES VACCINE; METHOTREXATE; TETANUS ANTIBODY; TETANUS TOXOID;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADD ON THERAPY; ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CHILD; CONTROLLED STUDY; DIPHTHERIA; FEMALE; HAEMOPHILUS INFECTION; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; HUMORAL IMMUNITY; MAJOR CLINICAL STUDY; MALE; MEASLES; PRIORITY JOURNAL; REVACCINATION; SIBLING; TETANUS;

ADOLESCENT; ANTIBODY FORMATION; BACTERIAL VACCINES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DIPHTHERIA; HAEMOPHILUS INFLUENZAE TYPE B; HUMANS; MEASLES; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TETANUS; VACCINATION; VIRAL VACCINES;

EID: 71049129495     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22135     Document Type: Article

References (26)

1. Alanko S, Pelliniemi TT, Salmi TT. Recovery of blood Blymphocytes and serum immunoglobulins after chemotherapy for childhood acute lymphoblastic leukemia. Cancer 1992;69:1481-1486.
2. Kantar M, Çetingül N, Kansoy S, et al. Immune deficiency following cancer treatment in children. J Trop Pediatr 2003;49: 286-290. (Pubitemid 37304175)
3. Ek T, Mellander L, Hahn-Zoric M, et al. Intensive treatment for childhood acute lymphoblastic leukemia reduces immune responses to diphtheria, tetanus, and haemophilus influenzae type b. J Pediatr Hematol Oncol 2004;26:727-734. (Pubitemid 39577720)
4. Layward L, Levinsky RJ, Butler M. Long-term abnormalities in T and B lymphocyte function in children following treatment for acute lymphoblastic leukemia. Br J Haematol 1981;49:251-258. (Pubitemid 11061478)
5. Katz J, Walter BN, Bennets GA. Abnormal cellular and humoral immunity in childhood acute lymphoblastic leukemia in long-term remission. West J Med 1987;146:179-187. (Pubitemid 17052334)
6. Nilsson A, De Milito A, Engstrom P, et al. Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigens. Pediatrics 2002; 109:e91.
7. Kung FH, Orgel HA, Wallace WW, et al. Antibody production following immunisation with diphtheria and tetanus toxoids in children receiving chemotherapy during remission of malignant disease. Pediatrics 1984;74:86-89.
8. Rautonen J, Siimes MA, Lundstrom U, et al. Vaccination of children during treatment for leukemia. Acta Paediatr Scand 1986; 75:579-585.
9. Cheson BD. Infectious and immunosuppressive complications of purine analog therapy. J Clin Oncol 1995;13:2431-2448.
10. Fauci AS, Dale DC, Balow JE. Glucocorticosteroid therapy: Mechanisms of action and clinical considerations. Ann Intern Med 1976;84:304-315.
11. Möricke A, Reiter A, Zimmermann M, et al. Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: Treatment result of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood 2008;111:4477-4489.
12. Galazka AM. The immunological basis for immunization series (2); Diphtheria. Expanded Programme on Immunization. Geneva: WHO; 1993.
13. Galazka AM. The immunological basis for immunization series (3); Tetanus. Expanded Programme on Immunization. Geneva: WHO; 1993.
14. Plotkin SA. Immunologic correlates of protection induced by vaccination. Pediatr Infect Dis J 2001;20:63-75.
15. Anderson P. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type B. J Infect Dis 1984;149:1034.
16. Evans AS, KaslowRA. Viral infections of human, 4th edition. New York and London: Plenium Medical Book Company; 1997. pp. 508-509.
17. Erener Ercan T, Yüksel Soycan L, Apak H, et al. Antibody titers and immune response to diphtheria-tetanus-pertussis and measles-mumps-rubella vaccination in children treated for acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2005;27:273-277. (Pubitemid 40705809)
18. van der Does-van den Berg A, Hermans J, Nagel J, et al. Immunity to diphtheria, pertussis, tetanus, and poliomyelitis in children with acute lymphoblastic leukemia after cessation of chemotherapy. Pediatrics 1981;67:222-229. (Pubitemid 11184025)
19. Mustafa MM, Buchanan GR, Winick NJ, et al. Immune recovery in children with malignancy after cessation of chemotherapy. J Pediatr Hematol Oncol 1998;20:451-457.
20. Pichichero ME, Anderson EL, Rennels MB, et al. Fifth vaccination with diphtheria, tetanus and acellular pertussis is beneficial in four- to six-year-olds. Pediatr Infect Dis J 2001;20:427-433.
21. Patel SR, Ortin M, Cohen BJ, et al. Revaccination of children after completion of standard chemotherapy for acute leukemia. Clin Infect Dis 2007;44:635-642. (Pubitemid 46272970)
22. Brodtman DH, Rosenthal DW, Render A, et al. Immunodeficiency in children with acute lymphoblastic leukemia after completion of modern aggressive chemotherapeutic regimens. J Pediatr 2005; 146:654-661.
23. Fioredda F, Plebani A, Hanau G, et al. Re-immunisation schedule in leukemic children after intensive chemotherapy: A possible strategy. Eur J Haematol 2005;74:20-23. (Pubitemid 40143682)
24. Zignol M, Peracchi M, Tridello G, et al. Assesment of humoral immunity to poliomyelitis, tetanus, hepatit B, measles, rubella, and mumps in children after chemotherapy. Cancer 2004;101:635-641. (Pubitemid 38970616)
25. Chisholm J. Reimmunization after therapy for childhood cancer. Clin Infect Dis 2007;44:643-645.
26. van Tilburg CM, Sanders EA, Rovers MM, et al. Loss of antibodies and response to (re-) vaccination in children after treatment for acute lymphocytic leukemia: A systemic review. Leukemia 2006; 20:1717-1722.